etanidazole has been researched along with Chronic Illness in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergeron, M | 1 |
| Evans, SM | 1 |
| Sharp, FR | 1 |
| Koch, CJ | 1 |
| Lord, EM | 1 |
| Ferriero, DM | 1 |
1 other study available for etanidazole and Chronic Illness
| Article | Year |
|---|---|
Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.
Topics: Acute Disease; Animals; Animals, Newborn; Antibodies, Monoclonal; Brain; Cell Hypoxia; Cerebral Cort | 1999 |